Home

COMETRIQ

For more information about COMETRIQ™ (cabozantinib) capsules, including the Important Safety Information and Boxed Warning, go to www.COMETRIQ.com.

  • About Us
    • Management
    • Board of Directors
    • Collaborations
    • Locations
    • Contact Us
  • COMETRIQ™
  • Pipeline
    • GDC-0973 (XL518)
    • Partnered Compounds
  • Clinical Trials
    • Exelixis Clinical Trials
    • National Cancer Institute Sponsored Trials
    • Investigator Sponsored Trials
    • FAQs about Clinical Trials
  • Medical Information
  • Investors & Media
    • Management and Board
    • Corporate Governance
    • Stock Information
    • Analyst Coverage
    • Earnings Estimates
    • Earnings Ratings
    • Annual Reports
    • SEC Filings
    • Press Releases
    • Event Calendar
    • Media Resources
    • Information Request
    • Investor FAQs
    • Contact IR
  • Careers
    • Job Opportunities

Contact Us

Exelixis, Inc.

210 East Grand Avenue
So. San Francisco, CA 94080
(650) 837-7000 phone
(650) 837-8300 fax

© Exelixis, Inc. 2013   Website design: Hane Chow, Inc.
  • Privacy
  • Terms of Use